Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Multi-agency report highlights importance of reducing antibiotic use

https://www.ema.europa.eu/en/news/multi-agency-report-highlights-importance-reducing-antibiotic-use

Ryan McArthur 22 February 2024 All news
  • ← Annual report on the use of the special contribution for orphan medicinal products
  • Medical cannabis: update on the final year of testing and the arrival of cannabis-based medicines →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • FAQs: Introduction to the Clinical Trials Regulation (EU) No 536/2014 – CTIS Training Programme – Module 01
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10-13 February 2025
  • CHARGE(E) DE PHARMACOVIGILANCE HYBRIDE
Copyright © 2018 - Pharmya - Legal terms - Quality Policy